What hormones should be tested in a 33-year-old female patient on birth control (hormonal contraception) with secondary amenorrhea, hot flashes, fatigue, brain fog, irritability, and weight gain, despite normal thyroid function tests?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hormonal Testing for Secondary Amenorrhea in a 33-Year-Old on Birth Control

In a 33-year-old woman on hormonal contraception with secondary amenorrhea and symptoms of hot flashes, fatigue, brain fog, irritability, and weight gain, you should test FSH, LH, estradiol, prolactin, and consider DHEA-S and testosterone to rule out premature ovarian insufficiency, hyperprolactinemia, and hyperandrogenism, despite the confounding effect of exogenous hormones. 1, 2, 3

Critical Context: Birth Control Complicates Interpretation

  • Hormonal contraceptives suppress the hypothalamic-pituitary-ovarian axis, making interpretation of sex hormone levels challenging while on treatment. 4
  • Amenorrhea on birth control is expected and typically benign, but her constellation of symptoms (hot flashes, fatigue, brain fog) suggests possible underlying pathology that predated or exists independently of contraceptive use. 4
  • The key question is whether she has true ovarian insufficiency or another endocrine disorder that the birth control is masking. 1, 3

Recommended Hormonal Panel

Essential First-Line Tests (While Still on Birth Control):

  • Prolactin: Hyperprolactinemia accounts for 20% of secondary amenorrhea cases and can cause all her symptoms. The threshold for abnormal is >20 μg/L. 5, 6
  • FSH and LH: Ideally measured as an average of three samples taken 20 minutes apart. FSH >40 mIU/mL indicates primary ovarian insufficiency, which can occur even at age 33. 7, 5
  • Estradiol: Low levels suggest ovarian insufficiency; this helps distinguish true premature ovarian failure from contraceptive-induced suppression. 7, 2

Additional Tests to Consider:

  • DHEA-S and total/free testosterone: Elevated androgens suggest PCOS or adrenal pathology. DHEA-S is primarily adrenal in origin, and marked elevation warrants further adrenal evaluation. 5, 6
  • Morning cortisol or 24-hour urine cortisol: Her symptom cluster (weight gain, fatigue, irritability) could suggest Cushing's syndrome, which can present with amenorrhea and central hypogonadism. 8

Optimal Testing Strategy

The most accurate approach is to have her discontinue hormonal contraception for 6-8 weeks before testing, then repeat the hormonal panel. 1, 9, 3

  • If she cannot or will not stop contraception, proceed with testing now, but interpret results cautiously knowing that exogenous hormones will suppress FSH, LH, and estradiol. 4
  • If prolactin is elevated (>20 μg/L), repeat as a morning resting sample to confirm, as stress can cause spurious elevation. 5, 6
  • If prolactin remains elevated on repeat testing, order pituitary MRI to exclude prolactinoma. Prolactin >4,000 mU/L typically indicates prolactinoma. 5, 6

Critical Pitfalls to Avoid

  • Do not assume amenorrhea on birth control is benign without investigating her systemic symptoms. Hot flashes at age 33 are particularly concerning for premature ovarian insufficiency. 7, 3
  • Amenorrhea following oral contraceptive use does not imply causation—investigation should aim at determining the underlying cause, not attributing it to "post-pill amenorrhea." 9
  • Hyperprolactinemia itself causes anovulation by suppressing kisspeptin and gonadotropin secretion, making it difficult to distinguish from PCOS initially. 5, 6
  • If FSH is elevated suggesting ovarian insufficiency, patients can maintain unpredictable ovarian function and should not be presumed infertile—they may still need contraception. 1, 3

ICD-10 Coding

Use N91.1 (Secondary amenorrhea) as the primary diagnosis. 1, 3

Additional codes to consider based on symptoms:

  • R61 (Generalized hyperhidrosis) for hot flashes
  • R53.83 (Fatigue)
  • R41.840 (Attention and concentration deficit) for brain fog
  • R45.4 (Irritability and anger)
  • E66.9 (Obesity, unspecified) or R63.5 (Abnormal weight gain) if applicable

If testing reveals specific pathology:

  • E28.310 (Symptomatic premature menopause) if FSH >40 mIU/mL
  • E22.1 (Hyperprolactinemia) if prolactin elevated
  • E28.2 (Polycystic ovarian syndrome) if criteria met after stopping contraception

Follow-Up Algorithm

  1. If prolactin >20 μg/L: Repeat morning resting sample → If confirmed elevated, order pituitary MRI. 5, 6
  2. If FSH >40 mIU/mL: Diagnose premature ovarian insufficiency → Consider hormone replacement therapy for bone and cardiovascular protection. 7, 3
  3. If androgens elevated: Evaluate for PCOS (after stopping contraception) or adrenal pathology. 5, 6
  4. If all hormones normal on contraception: Have her stop birth control for 6-8 weeks and reassess to determine if she has spontaneous menses. 1, 3

References

Research

Amenorrhea: an approach to diagnosis and management.

American family physician, 2013

Research

Evaluation of amenorrhea.

American family physician, 1996

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Hyperprolactinemia and Hyperandrogenism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hyperprolactinemia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Evaluation and Management of Irregular Bleeding and Fertility in Women Over 50

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Amenorrhea as a presentation of Cushing's syndrome.

Endocrinology, diabetes & metabolism case reports, 2024

Research

The fallacy of the postpill amenorrhea syndrome.

Clinical obstetrics and gynecology, 1981

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.